USA Financial Formulas’s Halozyme HALO Stock Holding History

USA Financial Formulas’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$58.2K	Buy	743 +730	+5,615%	+$49.8K	0.01%	251
2026 Q1	$840	Hold	13	–	–	﹤0.01%	345
2025 Q4	$875	Sell	13 -3,619	-100%	-$243K	﹤0.01%	310
2025 Q3	$266K	Buy	+3,632	New	+$241K	0.05%	119
2023 Q4	–	Sell	-1,226	Closed	-$46.8K	–	429
2023 Q3	$46.8K	Hold	1,226	–	–	0.07%	203
2023 Q2	$44.2K	Sell	1,226 -70	-5%	-$2.39K	0.07%	179
2023 Q1	$49.5K	Buy	+1,296	New	+$60.8K	0.08%	132
2021 Q1	–	Sell	-4,011	Closed	-$171K	–	378
2020 Q4	$171K	Sell	4,011 -6,360	-61%	-$229K	0.14%	126
2020 Q3	$273K	Buy	+10,371	New	+$289K	0.21%	95

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

USA Financial Formulas's HALO Position: Q2 2026 in Review

USA Financial Formulas increased its Halozyme (HALO) stake by 5,615% in Q2 2026, buying an estimated $49.8K and bringing the position to 743 shares worth $58.2K. The position accounts for 0.01% of the portfolio, ranked #251.

USA Financial Formulas first reported a position in HALO in Q3 2020 and has held it in 9 quarters since. The position peaked at $273K in Q3 2020. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

USA Financial Formulas held 743 shares of Halozyme worth $58.2K as of Q2 2026.
USA Financial Formulas bought 730 Halozyme shares in Q2 2026, an estimated $49.8K.
Halozyme made up 0.01% of USA Financial Formulas's portfolio in Q2 2026, its #251 holding.
USA Financial Formulas first reported a position in Halozyme in Q3 2020 and has held it in 9 quarters since.
USA Financial Formulas's Halozyme position peaked at $273K in Q3 2020.
668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on USA Financial Formulas's 13F filing for Q2 2026, filed 4 Aug 2026.